“Impact of Severity and Disease Course on Baricitinib Treatment Response in Adolescent Patients with Severe AA from the BRAVE-AA-PEDS Trial”., J of Skin, vol. 9, no. 6, p. s665, Nov. 2025, doi: 10.25251/0fqz5v46.